26 May 2023 | News
To address critical global health challenges by accelerating and optimising innovative product development
Image credit: shutterstock
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute $200 million to the Global Health Innovative Technology Fund (GHIT Fund)/United Nations Development Programme (UNDP).
This pledge supports the GHIT Fund's third phase of operations, including investments in research and development (R&D) of drugs, vaccines and diagnostics, utilising Japan's innovation and expertise to prevent and address infectious diseases such as tuberculosis, malaria and neglected tropical diseases (NTDs), which are highly prevalent in low- and middle-income countries.
In addition to the new contribution from the Government of Japan, support from industry for GHIT's replenishment has increased compared to previous replenishments.
Over the next five years, the GHIT Fund will strive to secure additional support with a total replenishment goal of $400 million to support operations and investments. This replenishment supports the implementation of "GHIT 3.0," the institution's third five-year plan.
As per 25 May 2023, the GHIT Fund has invested a total of approximately 29.1 billion yen in 118 projects. Currently, 53 projects are ongoing, including 26 targeted and exploratory research projects, 15 non-clinical trials and 12 clinical trials.